Molecular Therapy-Nucleic Acids

Papers
(The H4-Index of Molecular Therapy-Nucleic Acids is 47. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
All roads lead to cure: Diversity of oligonucleotides in DM1 therapy151
Modulation of miR-29 influences myocardial compliance likely through coordinated regulation of calcium handling and extracellular matrix99
Endothelial derived, secreted long non-coding RNAs Gadlor1 and Gadlor2 aggravate cardiac remodeling90
A bimolecular modification strategy for developing long-lasting bone anabolic aptamer88
RETRACTED: HOXA5-miR-574-5p axis promotes adipogenesis and alleviates insulin resistance85
Efficient transfected liposomes co-loaded with pNrf2 and pirfenidone improves safe delivery for enhanced pulmonary fibrosis reversion84
Single-swap editing for the correction of common Duchenne muscular dystrophy mutations79
MicroRNA-466 and microRNA-200 increase endothelial permeability in hyperglycemia by targeting Claudin-579
Forced enhancer-promoter rewiring to alter gene expression in animal models78
Gene-repressing epigenetic reader EED unexpectedly enhances cyclinD1 gene activation78
Emerging roles of circRNAs in the pathological process of myocardial infarction78
Cas-CLOVER is a novel high-fidelity nuclease for safe and robust generation of TSCM-enriched allogeneic CAR-T cells77
Retraction Notice to: Hypoxic tumor-derived exosomal circular RNA SETDB1 promotes invasive growth and EMT via the miR-7/Sp1 axis in lung adenocarcinoma70
Mitochondrial double-stranded RNAs as a pivotal mediator in the pathogenesis of Sjӧgren’s syndrome70
Alleviation of ischemia-reperfusion induced renal injury by chemically modified SOD2 mRNA delivered via lipid nanoparticles69
Effective intravitreal gene delivery to retinal pigment epithelium with hyaluronic acid nanospheres68
Insights into the regulatory role of epigenetics in moyamoya disease: Current advances and future prospectives66
SPRINGing forward: Advancing RNA editing efficiency and precision with engineered ADAR266
Novel insights into the interaction between N6-methyladenosine modification and circular RNA64
Highly efficient A-to-G base editing by ABE8.17 in rabbits63
Antisense oligonucleotide-mediated exon 27 skipping restores dysferlin function in dysferlinopathy patient-derived muscle cells62
Single-cell transcriptome profiling implicates the psychological stress-induced disruption of spermatogenesis62
AAV-vectored base editor trans-splicing delivers dystrophin repair60
LinQURE: A novel AAV gene silencing platform that supports multi-transcript targeting for complex disorders58
Implications of miR-148a-3p/p35/PTEN signaling in tau hyperphosphorylation and autoregulatory feedforward of Akt/CREB in Alzheimer’s disease57
Unlocking RNA mysteries: Predicting subcellular localizations with AI56
An oversized AAV8 vector to deliver CPS156
Durable HTT silencing using non-evolved dCas9 epigenome editors in patient-derived cells55
Ferroptosis as a therapeutic target in glioblastoma: Mechanisms and emerging strategies52
A potent GalNAc-siRNA drug, RBD1016, leads to sustained HBsAg reduction and seroconversion in mouse models of HBV infection52
Implications of circular transcripts in DM1 pathomechanism52
Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 151
Discovery of peptides for ligand-mediated delivery of mRNA lipid nanoparticles to cystic fibrosis lung epithelia51
Enhanced molecular dynamic simulation studies unravel long-range effects caused by sequence variations and partner binding in RNA aptamers51
Inefficacy of anti-VEGF therapy reflected in VEGF-mediated photoreceptor degeneration51
RNA therapeutics in targeting G protein-coupled receptors: Recent advances and challenges51
Antitumor effects of chemically modified miR-143 lipoplexes in a mouse model of pelvic colorectal cancer via myristoylated alanine-rich C kinase substrate downregulation50
RETRACTED: LncRNA PVT1 promotes tumorigenesis of glioblastoma by recruiting COPS5 to deubiquitinate and stabilize TRIM2450
A conditional RNA Pol II mono-promoter drives HIV-inducible, CRISPR-mediated cyclin T1 suppression and HIV inhibition50
Topical application of a CCL22-binding aptamer suppresses contact allergy49
Extracellular viral microRNAs as biomarkers of virus infection in human cells49
Towards SINEUP-based therapeutics: Design of an in vitro synthesized SINEUP RNA49
Redefining NSP12 activity in SARS-CoV-2 and its regulation by NSP8 and NSP749
CleanCap M6 inhibits decapping of exogenously delivered IVT mRNA48
Unlocking the therapeutic potential of locked nucleic acids through lipid nanoparticle delivery48
miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD4448
Heterogeneity of human corneal endothelium implicates lncRNA NEAT1 in Fuchs endothelial corneal dystrophy48
A genome-wide CRISPR screen unveils the endosomal maturation protein WDR91 as a promoter of productive ASO activity in melanoma47
DNA-PKcs inhibition improves sequential gene insertion of the full-length CFTR cDNA in airway stem cells47
Deficiency of miR-409-3p improves myocardial neovascularization and function through modulation of DNAJB9/p38 MAPK signaling47
0.24453806877136